Cost of benign versus oncologic colon resection among fee-for-service Medicare enrollees.

ABSTRACT: BACKGROUND AND OBJECTIVES:Reimbursement for colonic pathology by the Centers for Medicare and Medicaid Services (CMS) are grouped in the Medicare Severity-Diagnosis Related Groups (MS-DRG). With limited available data, we sought to compare the relative impact of malignant vs benign colonic pathology on reimbursement under the MS-DRG system. METHODS:We used 5% national Medicare data from 2011 to 2014. Patients were classified as having benign disease or malignancy. Descriptive statistics and multivariate regression analysis were used to evaluate the surgical approach and health resource utilization. RESULTS:Of 10?928 patients, most were Non-Hispanic White women. The majority underwent open colectomy in both cohorts (P?

SUBMITTER: Hughes BD 

PROVIDER: S-EPMC6635007 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature